SCD and myeloid sarcoma: Collectively, this review emphasizes the crucial role of SCD1 in contributing to the pathogenesis of diverse neurodegenerative and neuroinflammatory disorders, thereby highlighting the therapeutic potential of SCD1 modulation in conditions such as MS, AD, and PD.